Noteworthy

Aug 11, 2017
Pharmaceutical Executive
IFPMA's new Assistant Director General speaks about her mission to use the organization’s international reach to find real and practical solutions to the most pressing global healthcare challenges.
Aug 09, 2017
Pharmaceutical Executive
Pharm Exec’s 13th Annual Press Audit reveals a tonal undercurrent in sync with an industry unable to escape the glare of scrutiny.
Aug 07, 2017
The significance of real-world data has been not utilized to the full potential, writes Uttam Barick.
Aug 07, 2017
Jill Wechsler on the Senate's 94-1 vote to approve legislation reauthorizing user fees and a series of program changes to maintain a smoothly functioning FDA product review and approval process.
Aug 06, 2017
Female students pursuing a Science, Technology, Engineering, and Mathematics (STEM) pathway need earlier enticement and more C-suite role models, writes Mylan’s Head of Global Commercial Development, Adele Gulfo.
Jul 31, 2017
Time will determine the shape of biosimilar usage in oncology, but they will play a significant role in the battle against cancer in the future, writes Alessandra Franceschetti.
Jul 31, 2017
Internal oversight and the tools to remain compliant are critical to companies seeking to avoid corporate integrity agreements or efficiently fulfill existing agreements, writes Gabriela P. Baron.
Jul 26, 2017
Tensions are becoming clear within industry as it faces what might yet be the toughest negotiations on pricing with the UK government. Leela Barham reports.
Jul 26, 2017
More pharma companies are reporting that their digital strategies are ineffective compared to other industries. Heath Jackson looks at why this is – and what they need to do about it.
Jul 24, 2017
Pharmaceutical Executive
Excitement over more new treatments for cancer and rare diseases is offset by cringing over prices.
native1_300x100
lorem ipsum